Título / AutorAño
Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
S Madsbad
Diabetes, Obesity and Metabolism 18 (4), 317-332
2016
Ghrelin, CCK, GLP-1, and PYY (3–36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB
RE Steinert, C Feinle-Bisset, L Asarian, M Horowitz, C Beglinger, N Geary
Physiological reviews 97 (1), 411-463
2016
Neural control of energy balance: translating circuits to therapies
L Gautron, JK Elmquist, KW Williams
Cell 161 (1), 133-145
2015
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
C Sorli, S Harashima, GM Tsoukas, J Unger, JD Karsbøl, T Hansen, ...
The lancet Diabetes & endocrinology 5 (4), 251-260
2017
Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial
M Davies, TR Pieber, ML Hartoft-Nielsen, OKH Hansen, S Jabbour, ...
Jama 318 (15), 1460-1470
2017
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
AJ Ahmann, M Capehorn, G Charpentier, F Dotta, E Henkel, I Lingvay, ...
Diabetes Care 41 (2), 258-266
2018
Toward a wiring diagram understanding of appetite control
ML Andermann, BB Lowell
Neuron 95 (4), 757-778
2017
Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia
JP Krieger, M Arnold, KG Pettersen, P Lossel, W Langhans, SJ Lee
Diabetes 65 (1), 34-43
2016
The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer’s disease
HH Hansen, K Fabricius, P Barkholt, ML Niehoff, JE Morley, J Jelsing, ...
Journal of Alzheimer's Disease 46 (4), 877-888
2015
Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain
KM Heppner, M Kirigiti, A Secher, SJ Paulsen, R Buckingham, C Pyke, ...
Endocrinology 156 (1), 255-267
2015
Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
LL Baggio, DJ Drucker
The Journal of clinical investigation 124 (10), 4223-4226
2014
The L-cell in nutritional sensing and the regulation of appetite
E Spreckley, KG Murphy
Frontiers in nutrition 2, 23
2015
Mechanisms of action and therapeutic application of glucagon-like peptide-1
DJ Drucker
Cell metabolism 27 (4), 740-756
2018
Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons
XF Wang, JJ Liu, J Xia, J Liu, V Mirabella, ZP Pang
Cell reports 12 (5), 726-733
2015
Half‐life extension of biopharmaceuticals using chemical methods: alternatives to PEGylation
SB van Witteloostuijn, SL Pedersen, KJ Jensen
ChemMedChem 11 (22), 2474-2495
2016
Liraglutide and obesity: a review of the data so far
EE Ladenheim
Drug design, development and therapy 9, 1867
2015
GLP-1 and weight loss: unraveling the diverse neural circuitry
SE Kanoski, MR Hayes, KP Skibicka
American Journal of Physiology-Regulatory, Integrative and Comparative …
2016
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
KM Heppner, D Perez-Tilve
Frontiers in neuroscience 9, 92
2015
Incretin hormones: their role in health and disease
MA Nauck, JJ Meier
Diabetes, Obesity and Metabolism 20, 5-21
2018
Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes
MV Lourenco, ST Ferreira, FG De Felice
Progress in neurobiology 129, 37-57
2015
1 - 20
Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.